- DBT allocates Rs 200 cr to set up National Stem Cell Institute in Karnataka - pharmabiz.com
- Human clinical trial of stem cell-based drug - Times of India
- ASEAN harmonises drug registration norms, CTD filing to be mandatory from 2012 - pharmabiz.com
- CREMA plans to launch Third Party Audit training programme - pharmabiz.com
- New diabetes drug approved without trial - Livemint
Stempeutics to launch its stem cell based new drug in India by 2012 - pharmabiz.com
Stempeutics to launch its stem cell based new drug in India by 2012pharmabiz.comThe company has contracted Acunova, a Bangalore based CRO, to conduct the clinical trials in India and Malaysia. The trials for acute myocardial infarction ...
